LB
Lance Baller
Director10% Owner

Lance Baller insider trades: Selectis Health (GBCS) stock purchases

Director, Selectis Health Last trade Dec 18, 2025 18 Form 4 filings
$0
Sold, last 12 months
0 sales
$14K
Bought, last 12 months
1 buy
8
Open-market trades
since 2015
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Lance reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 18, 2025GBCS↑ Buy$14K
Oct 6, 2022GBCS↑ Buy$3K
Jan 7, 2016GBCS↑ Buy$19K
Jan 5, 2016GBCS↑ Buy$19K
Dec 22, 2015GBCS↑ Buy$10K
Dec 17, 2015GBCS↑ Buy$5K
Sep 10, 2015GBCS↑ Buy$33K
Sep 9, 2015GBCS↑ Buy$8K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Lance Baller's insider trades

Lance Baller is a director at Selectis Health (GBCS). Since Sep 9, 2015, Lance has reported 8 open-market purchases worth $111K and no sales on SEC Form 4. In the last 12 months: 1 buy ($14K).

Their filings also include grants and awards (14 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GBCS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.